June 13, 2024
We reiterate our Outperform on the shares of Celestica (CLS; $56.77) and bump up our target from $60 to $65 after we had the opportunity for a “big picture” discussion with CEO Rob Mionis, who…
May 15, 2024
We initiate coverage with an Outperform and $60 target on the shares of Celestica (CLS; $48.00), an electronics manufacturing services (EMS) provider, which after completing a portfolio transformation in 2021 is now well focused on…